PHASE II TRIAL OF INFUSIONAL CYCLOPHOSPHAMIDE, DOXORUBICIN, & ETOPOSIDE (CDE) IN HIV-ASSOCIATED NON-HODGKIN'S LYMPHOMA (NHL): AN EASTERN COOPERATIVE ONCOLOGY GROUP (ECOG) TRIAL (E1494).